John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Independent Bank Corp
IBCP
$815M
| $662K | ﹤0.01% |
35,838
-78
| -0.2% | -$1.28K |
|
2302
PUT
APA Corp
APA
$14.5B
| $661K | ﹤0.01% |
46,600
-158,000
| -77% | -$1.84M |
|
|
PLAN
2303
PUT
DELISTED
Anaplan, Inc.
PLAN
| $661K | ﹤0.01% |
+9,200
| New | +$598K |
|
2304
CALL
Centene
CNC
$32.1B
| $660K | ﹤0.01% |
11,000
+7,000
| +175% | +$445K |
|
2305
Sensient Technologies
SXT
$5.82B
| $659K | ﹤0.01% |
8,936
-126,129
| -93% | -$8.8M |
|
2306
Matthews International
MATW
$671M
| $658K | ﹤0.01% |
22,381
-8,598
| -28% | -$222K |
|
2307
CALL
NovoCure
NVCR
$2.05B
| $658K | ﹤0.01% |
+3,800
| New | +$520K |
|
2308
PUT
Intercontinental Exchange
ICE
$90.8B
| $657K | ﹤0.01% |
+5,700
| New | +$592K |
|
2309
PUT
Constellation Brands
STZ
$23.1B
| $657K | ﹤0.01% |
3,000
-5,000
| -63% | -$983K |
|
2310
Designer Brands
DBI
$280M
| $656K | ﹤0.01% |
+85,761
| New | +$571K |
|
2311
CALL
Crown Castle
CCI
$32.5B
| $653K | ﹤0.01% |
+4,100
| New | +$665K |
|
|
SWIR
2312
DELISTED
Sierra Wireless
SWIR
| $653K | ﹤0.01% |
+44,727
| New | +$562K |
|
2313
Cannae Holdings
CNNE
$677M
| $651K | ﹤0.01% |
+14,700
| New | +$597K |
|
2314
CALL
Celanese
CE
$4.89B
| $650K | ﹤0.01% |
5,000
+1,600
| +47% | +$199K |
|
2315
Covenant Logistics
CVLG
$890M
| $650K | ﹤0.01% |
87,834
-37,562
| -30% | -$315K |
|
2316
CALL
Idexx Laboratories
IDXX
$43.3B
| $650K | ﹤0.01% |
1,300
-3,600
| -73% | -$1.61M |
|
2317
PUT
STAAR Surgical
STAA
$1.16B
| $650K | ﹤0.01% |
8,200
+3,400
| +71% | +$249K |
|
2318
PUT
Cirrus Logic
CRUS
$5.58B
| $649K | ﹤0.01% |
7,900
+1,300
| +20% | +$97.7K |
|
2319
PUT
State Street Financial Select Sector SPDR ETF
XLF
$56.9B
| $649K | ﹤0.01% |
22,000
-4,000
| -15% | -$107K |
|
|
K
2320
CALL
DELISTED
Kellanova
K
| $647K | ﹤0.01% |
11,076
-11,715
| -51% | -$704K |
|
|
CTRA
2321
PUT
DELISTED
Coterra Energy
CTRA
| $646K | ﹤0.01% |
39,700
+16,700
| +73% | +$293K |
|
2322
PUT
Ollie's Bargain Outlet
OLLI
$4.51B
| $646K | ﹤0.01% |
7,900
-18,500
| -70% | -$1.62M |
|
|
AMED
2323
CALL
DELISTED
Amedisys
AMED
| $645K | ﹤0.01% |
+2,200
| New | +$564K |
|
2324
CALL
Dine Brands
DIN
$449M
| $644K | ﹤0.01% |
11,100
-5,400
| -33% | -$328K |
|
2325
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.04B
| $644K | ﹤0.01% |
12,400
-72,700
| -85% | -$3.32M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.